Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION ...
{{id}} {{{paragraph}}}
Example: barber
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These HIGHLIGHTS do not include all the INFORMATION needed to use BRAVELLE safely and effectively. See full PRESCRIBING INFORMATION for BRAVELLE BRAVELLE (urofollitropin for injection, purified) for subcutaneous or intramuscular injection Initial Approval: 2002 ---------------------RECENT MAJOR CHANGES---------------------- Dosage and Administration ( ) 2/2014 Contraindications (4) 2/2014 Warnings and Precautions Ovarian Hyperstimulation Syndrome (OHSS) ( ) 2/2014 Pulmonary and Vascular Complications ( ) 2/2014 Ovarian Torsion ( ) 2/2014 Multi-fetal Gestation and Birth ( ) 2/2014 Congenital Malformations ( ) 2/2014 Ectopic Pregnancy ( ) 2/2014 Spontaneous Abortion ( ) 2/2014 Ovarian Neoplasms ( ) 2/2014 ----------------------INDICATIONS AND USAGE----------------------- BRAVELLE (urofollitropin for injection, purified) is a gonadotropin indicated for.
Discourage intercourse when the risk for OHSS is increased [see Warnings and Precautions (5.2, 5.3)]. 2.3 Recommended Dosing for Assisted Reproduction Technology The recommended dosing scheme for patients undergoing IVF follows a stepwise approach and is individualized for each
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: